Article

Duke Discovery Yields Potential New Treatment for Gout

A new gout treatment can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments.

A new gout treatment can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Related Content
Orrin Troum, MD, clinical professor of medicine, Keck School of Medicine, University of Southern California, and director, clinical rheumatology research, Providence St John's Hospital, Santa Monica, California
November 22nd 2024

Shortened Pegloticase Infusions Feasible for Uncontrolled Gout, Reduces Treatment Burden

Victoria Johnson
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Søren Andrea Just, MD, PhD, associate professor, University of Southern Denmark, and Odense University Hospital – Svendborg.
November 21st 2024

AI Assessments, Robotics Perform to Rheumatologist Levels in Joint Assessment

Victoria Johnson
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
April 17th 2024

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Megan Clowse, MD, MPH, Associate Professor of Medicine, Associate Professor in Obstetrics and Gynecology, and Associate Professor in Population Health Sciences, and Chief of the Division of Rheumatology and Immunology, Duke University School of Medicine
November 19th 2024

DZP Improves Disease Activity and Reduces Corticosteroid Use in SLE

Victoria Johnson
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
November 19th 2024

Vagus Nerve Stimulation Yields Responses in Refractory Rheumatoid Arthritis

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.